Loading…
Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411
A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same k...
Saved in:
Published in: | Journal of computer-aided molecular design 1995-12, Vol.9 (6), p.465-472 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3 |
container_end_page | 472 |
container_issue | 6 |
container_start_page | 465 |
container_title | Journal of computer-aided molecular design |
container_volume | 9 |
creator | Furet, P Caravatti, G Lydon, N Priestle, J P Sowadski, J M Trinks, U Traxler, P |
description | A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase. |
doi_str_mv | 10.1007/BF00124317 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77901518</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>77901518</sourcerecordid><originalsourceid>FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</originalsourceid><addsrcrecordid>eNpFkE1LAzEYhIMotVYv3oWcPAir-dpN4k2LrUJFDwrelmSTbaPbbN1kC_33prbo6R14nxmYAeAco2uMEL-5nyCECaOYH4AhzjnNmMzxIRgiSVBW5OzjGJyE8IkSLAs0AAPBhcRCDMH6uTW2aZyfwxB7s4FtDVddG63z8Mt5FSx0fuG0i20XbqF23mzZZXJt0RBV37Vh1XbOW6i8gUnNkzf94sLCYBtbRbd28Td5PH2FOWEYn4KjWjXBnu3vCLxPHt7Gj9nsZfo0vptlFREkZoYqznODdUE0sRUuGKMVQpoWPOecCSbqQmhSW0K14ZpSYUghWW0wkwpLS0fgcpebOn33NsRy6UKVCitv2z6UnEuEcywSeLUDq1QndLYuV51bqm5TYlRuRy7_R07wxT6110tr_tD9qvQHPTt2mQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77901518</pqid></control><display><type>article</type><title>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</title><source>SpringerLink_过刊(NSTL购买)</source><creator>Furet, P ; Caravatti, G ; Lydon, N ; Priestle, J P ; Sowadski, J M ; Trinks, U ; Traxler, P</creator><creatorcontrib>Furet, P ; Caravatti, G ; Lydon, N ; Priestle, J P ; Sowadski, J M ; Trinks, U ; Traxler, P</creatorcontrib><description>A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.</description><identifier>ISSN: 0920-654X</identifier><identifier>EISSN: 1573-4951</identifier><identifier>DOI: 10.1007/BF00124317</identifier><identifier>PMID: 8789188</identifier><language>eng</language><publisher>Netherlands</publisher><subject>Alkaloids - chemistry ; Alkaloids - metabolism ; Alkaloids - pharmacology ; Binding Sites ; Computer Simulation ; Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors ; Cyclic AMP-Dependent Protein Kinases - chemistry ; Enzyme Inhibitors - chemistry ; Enzyme Inhibitors - metabolism ; Enzyme Inhibitors - pharmacology ; Hydrogen Bonding ; Models, Molecular ; Molecular Conformation ; Molecular Structure ; Phthalimides - chemistry ; Phthalimides - metabolism ; Phthalimides - pharmacology ; Protein Conformation ; Protein Kinase Inhibitors ; Protein Kinases - chemistry ; Receptor, Epidermal Growth Factor - antagonists & inhibitors ; Receptor, Epidermal Growth Factor - chemistry ; Staurosporine ; Thermodynamics</subject><ispartof>Journal of computer-aided molecular design, 1995-12, Vol.9 (6), p.465-472</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</citedby><cites>FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8789188$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Furet, P</creatorcontrib><creatorcontrib>Caravatti, G</creatorcontrib><creatorcontrib>Lydon, N</creatorcontrib><creatorcontrib>Priestle, J P</creatorcontrib><creatorcontrib>Sowadski, J M</creatorcontrib><creatorcontrib>Trinks, U</creatorcontrib><creatorcontrib>Traxler, P</creatorcontrib><title>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</title><title>Journal of computer-aided molecular design</title><addtitle>J Comput Aided Mol Des</addtitle><description>A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.</description><subject>Alkaloids - chemistry</subject><subject>Alkaloids - metabolism</subject><subject>Alkaloids - pharmacology</subject><subject>Binding Sites</subject><subject>Computer Simulation</subject><subject>Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors</subject><subject>Cyclic AMP-Dependent Protein Kinases - chemistry</subject><subject>Enzyme Inhibitors - chemistry</subject><subject>Enzyme Inhibitors - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Hydrogen Bonding</subject><subject>Models, Molecular</subject><subject>Molecular Conformation</subject><subject>Molecular Structure</subject><subject>Phthalimides - chemistry</subject><subject>Phthalimides - metabolism</subject><subject>Phthalimides - pharmacology</subject><subject>Protein Conformation</subject><subject>Protein Kinase Inhibitors</subject><subject>Protein Kinases - chemistry</subject><subject>Receptor, Epidermal Growth Factor - antagonists & inhibitors</subject><subject>Receptor, Epidermal Growth Factor - chemistry</subject><subject>Staurosporine</subject><subject>Thermodynamics</subject><issn>0920-654X</issn><issn>1573-4951</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><recordid>eNpFkE1LAzEYhIMotVYv3oWcPAir-dpN4k2LrUJFDwrelmSTbaPbbN1kC_33prbo6R14nxmYAeAco2uMEL-5nyCECaOYH4AhzjnNmMzxIRgiSVBW5OzjGJyE8IkSLAs0AAPBhcRCDMH6uTW2aZyfwxB7s4FtDVddG63z8Mt5FSx0fuG0i20XbqF23mzZZXJt0RBV37Vh1XbOW6i8gUnNkzf94sLCYBtbRbd28Td5PH2FOWEYn4KjWjXBnu3vCLxPHt7Gj9nsZfo0vptlFREkZoYqznODdUE0sRUuGKMVQpoWPOecCSbqQmhSW0K14ZpSYUghWW0wkwpLS0fgcpebOn33NsRy6UKVCitv2z6UnEuEcywSeLUDq1QndLYuV51bqm5TYlRuRy7_R07wxT6110tr_tD9qvQHPTt2mQ</recordid><startdate>199512</startdate><enddate>199512</enddate><creator>Furet, P</creator><creator>Caravatti, G</creator><creator>Lydon, N</creator><creator>Priestle, J P</creator><creator>Sowadski, J M</creator><creator>Trinks, U</creator><creator>Traxler, P</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199512</creationdate><title>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</title><author>Furet, P ; Caravatti, G ; Lydon, N ; Priestle, J P ; Sowadski, J M ; Trinks, U ; Traxler, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Alkaloids - chemistry</topic><topic>Alkaloids - metabolism</topic><topic>Alkaloids - pharmacology</topic><topic>Binding Sites</topic><topic>Computer Simulation</topic><topic>Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors</topic><topic>Cyclic AMP-Dependent Protein Kinases - chemistry</topic><topic>Enzyme Inhibitors - chemistry</topic><topic>Enzyme Inhibitors - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Hydrogen Bonding</topic><topic>Models, Molecular</topic><topic>Molecular Conformation</topic><topic>Molecular Structure</topic><topic>Phthalimides - chemistry</topic><topic>Phthalimides - metabolism</topic><topic>Phthalimides - pharmacology</topic><topic>Protein Conformation</topic><topic>Protein Kinase Inhibitors</topic><topic>Protein Kinases - chemistry</topic><topic>Receptor, Epidermal Growth Factor - antagonists & inhibitors</topic><topic>Receptor, Epidermal Growth Factor - chemistry</topic><topic>Staurosporine</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Furet, P</creatorcontrib><creatorcontrib>Caravatti, G</creatorcontrib><creatorcontrib>Lydon, N</creatorcontrib><creatorcontrib>Priestle, J P</creatorcontrib><creatorcontrib>Sowadski, J M</creatorcontrib><creatorcontrib>Trinks, U</creatorcontrib><creatorcontrib>Traxler, P</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of computer-aided molecular design</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Furet, P</au><au>Caravatti, G</au><au>Lydon, N</au><au>Priestle, J P</au><au>Sowadski, J M</au><au>Trinks, U</au><au>Traxler, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411</atitle><jtitle>Journal of computer-aided molecular design</jtitle><addtitle>J Comput Aided Mol Des</addtitle><date>1995-12</date><risdate>1995</risdate><volume>9</volume><issue>6</issue><spage>465</spage><epage>472</epage><pages>465-472</pages><issn>0920-654X</issn><eissn>1573-4951</eissn><abstract>A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationship of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.</abstract><cop>Netherlands</cop><pmid>8789188</pmid><doi>10.1007/BF00124317</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0920-654X |
ispartof | Journal of computer-aided molecular design, 1995-12, Vol.9 (6), p.465-472 |
issn | 0920-654X 1573-4951 |
language | eng |
recordid | cdi_proquest_miscellaneous_77901518 |
source | SpringerLink_过刊(NSTL购买) |
subjects | Alkaloids - chemistry Alkaloids - metabolism Alkaloids - pharmacology Binding Sites Computer Simulation Cyclic AMP-Dependent Protein Kinases - antagonists & inhibitors Cyclic AMP-Dependent Protein Kinases - chemistry Enzyme Inhibitors - chemistry Enzyme Inhibitors - metabolism Enzyme Inhibitors - pharmacology Hydrogen Bonding Models, Molecular Molecular Conformation Molecular Structure Phthalimides - chemistry Phthalimides - metabolism Phthalimides - pharmacology Protein Conformation Protein Kinase Inhibitors Protein Kinases - chemistry Receptor, Epidermal Growth Factor - antagonists & inhibitors Receptor, Epidermal Growth Factor - chemistry Staurosporine Thermodynamics |
title | Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411 |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A15%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modelling%20study%20of%20protein%20kinase%20inhibitors:%20binding%20mode%20of%20staurosporine%20and%20origin%20of%20the%20selectivity%20of%20CGP%2052411&rft.jtitle=Journal%20of%20computer-aided%20molecular%20design&rft.au=Furet,%20P&rft.date=1995-12&rft.volume=9&rft.issue=6&rft.spage=465&rft.epage=472&rft.pages=465-472&rft.issn=0920-654X&rft.eissn=1573-4951&rft_id=info:doi/10.1007/BF00124317&rft_dat=%3Cproquest_cross%3E77901518%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c282t-d3a775d1b62b2ec16443c00b3675774848f68b2fe23bd7b338d2694fd149a19e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=77901518&rft_id=info:pmid/8789188&rfr_iscdi=true |